Younger adults with lung cancer more likely to have targetable genetic changes, study finds

A major international study led by researchers at Sylvester Comprehensive Cancer Center found that younger adults with non-small cell lung cancer are significantly more likely than older patients to carry genetic alterations that can be matched with targeted therapies. This discovery is important because it suggests that younger lung cancer patients may have better access to personalized treatment options based on their specific genetic profiles. Targeted therapies work by attacking cancer cells with specific genetic mutations, potentially offering more effective and less toxic treatments. These findings could lead to improved outcomes and quality of life for younger patients diagnosed with this common form of lung cancer.